A Review on Clinical Presentation and Treatment of Coronavirus (Covid 19)

Abstract

In 2021, 2022, and 2023, the following medications are used to treat and manage coronavirus: chloroquine, hydroxychloroquine, favipiravir; Remdesivir, tocilizumab, and anakinra. Analysis of the clinical presentations concerning COVID-19 was done between 2021 and 2023. When compared to other clinical presentations, fever, cough, chest pain, and dyspnea are the most frequently occurring clinical manifestations. Chloroquine and hydroxychloroquine are the medications most frequently used in the treatment management of COVID-19 to prevent the coronavirus between 2021 and 2023. It is commonly repeated clinical manifestations (Fever, Cough, Chest pain, dyspnea) when compared to other clinical presentations. In the treatment management of COVID-19, the drugs are (chloroquine, and hydroxychloroquine) most commonly used to prevent coronavirus from 2021 to 2023.